Biznesradar bez reklam? Sprawdź BR Plus
Wiadomości INC
1.520+0.040(+2.70%)INC SPÓŁKA AKCYJNA
GPW - Akcje/PDA - Notowania ciągłe
Biznesradar bez reklam? Sprawdź BR Plus
Broadwind, Inc.
The post Broadwind Releases Q1 2026 Financial Results first appeared on Alphastreet.
Olema Pharmaceuticals, Inc.
The post Olema Pharmaceuticals Releases Q1 2026 Financial Results first appeared on Alphastreet.
C4 Therapeutics, Inc.
The post C4 Therapeutics Releases Q1 2026 Financial Results first appeared on Alphastreet.
Unicycive Therapeutics, Inc.
The post Unicycive Therapeutics Releases Q1 2026 Financial Results first appeared on Alphastreet.
D-Wave Quantum Inc.
The post D-Wave Quantum Releases Q1 2026 Financial Results first appeared on Alphastreet.
Enanta Pharmaceuticals, Inc reported a narrower loss for its second quarter of fiscal 2026, as the biotechnology company's revenue growth helped offset continued development costs.
The post Enanta Pharmaceuticals Releases Q2 2026 Financial Results first appeared on Alphastreet.
ArriVent BioPharma Inc.
The post ArriVent BioPharma Releases Q1 2026 Financial Results first appeared on Alphastreet.
Sionna Therapeutics, Inc. (SION) posted Q1 2026 basic and diluted EPS of -$0.60.
The post Sionna Therapeutics Releases Q1 2026 Financial Results first appeared on Alphastreet.
CalciMedica, Inc.
The post CalciMedica Releases Q1 2026 Financial Results first appeared on Alphastreet.
Tenax Therapeutics, Inc.
The post Tenax Therapeutics Releases Q1 2026 Financial Results first appeared on Alphastreet.
Surf Air Mobility Inc.
The post Surf Air Mobility Releases Q1 2026 Financial Results first appeared on Alphastreet.
Janus International Group, Inc.
The post Janus International Group Releases Q1 2026 Financial Results first appeared on Alphastreet.
Erasca, Inc.
The post Erasca Releases Q1 2026 Financial Results first appeared on Alphastreet.
Under Armour, Inc.
The post Under Armour Releases Q4 2026 Financial Results first appeared on Alphastreet.
AN2 Therapeutics, Inc.
The post AN2 Therapeutics Releases Q1 2026 Financial Results first appeared on Alphastreet.
Q1 2026 non-GAAP basic and diluted net income per ADS earnings at Huya Inc. (HUYA) came in at ¥0.09 (RMB) per share, ahead of the ¥0.03 (RMB) consensus ...
The post Huya Releases Q1 2026 Financial Results first appeared on Alphastreet.
Vishay Precision Group, Inc.
The post Vishay Precision Group Releases Q1 2026 Financial Results first appeared on Alphastreet.
BETA Technologies, Inc.
The post BETA Technologies Releases Q1 2026 Financial Results first appeared on Alphastreet.
ProMIS Neurosciences, Inc.
The post ProMIS Neurosciences Releases Q1 2026 Financial Results first appeared on Alphastreet.
Earnings Beat Propels. Huya Inc. (NYSE:HUYA) delivered a strong earnings performance in Q1 2026, with non-GAAP basic and diluted net income per ADS of ¥0.09...
The post Huya Q1 2026 EPS Tops Expectations by 200.0%, Revenue Up 15% first appeared on Alphastreet.
Biznesradar bez reklam? Sprawdź BR Plus
Biznesradar bez reklam? Sprawdź BR Plus
Informacje
| ISIN: | PLINCLT00015 |
|---|---|
| Data debiutu: | 09.08.2006 |
| Liczba akcji: | 15 043 099 |
| Kapitalizacja: | 22 865 510 |
| Enterprise Value: | 22 478 510 |
| Branża: | Działalność inwestycyjna |
INC funkcjonuje w obszarze inwestycji oraz doradztwa na rynku kapitałowym. Spółka specjalizuje się w pomocy i wsparciu małym i średnim spółkom... INC funkcjonuje w obszarze inwestycji oraz doradztwa na rynku kapitałowym. Spółka specjalizuje się w pomocy i wsparciu małym i średnim spółkom działającym w różnych sektorach. Poza prywatnymi przedsiębiorstwami, INC świadczy również usługi doradcze jednostkom samorządu terytorialnego oraz angażuje się w projekty sportowe, kulturalne i akademickie.
| Nazwa: | INC SPÓŁKA AKCYJNA |
|---|---|
| Adres: | ul. Abpa Antoniego Baraniaka 6, 61-131, Poznań, Polska |
| CEO: | Paweł Śliwiński |
| NIP: | 7781024498 |
| REGON: | 630316445 |
| KRS: | 0000028098 |
| WWW: | http://www.incsa.pl/ |
Biznesradar bez reklam? Sprawdź BR Plus

